Melior Discovery, Inc. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Melior Discovery, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Melior Discovery, Inc. - Product Pipeline Review - 2014', provides an overview of the Melior Discovery, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Melior Discovery, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Melior Discovery, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Melior Discovery, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Melior Discovery, Inc.'s pipeline products

Reasons to buy

- Evaluate Melior Discovery, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Melior Discovery, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Melior Discovery, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Melior Discovery, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Melior Discovery, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Melior Discovery, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Melior Discovery, Inc. Snapshot 5
Melior Discovery, Inc. Overview 5
Key Information 5
Key Facts 5
Melior Discovery, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Melior Discovery, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Melior Discovery, Inc. - Pipeline Products Glance 10
Melior Discovery, Inc. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Melior Discovery, Inc. - Early Stage Pipeline Products 11
IND/CTA Filed Products/Combination Treatment Modalities 11
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Melior Discovery, Inc. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Melior Discovery, Inc. - Drug Profiles 15
MLR-1023 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
MLR-1017 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
MLR-1130 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
MLR-1362 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Insulin Analogs 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
MLR-1045 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Melior Discovery, Inc. - Pipeline Analysis 22
Melior Discovery, Inc. - Pipeline Products by Target 22
Melior Discovery, Inc. - Pipeline Products by Route of Administration 23
Melior Discovery, Inc. - Pipeline Products by Molecule Type 24
Melior Discovery, Inc. - Pipeline Products by Mechanism of Action 25
Melior Discovery, Inc. - Recent Pipeline Updates 26
Melior Discovery, Inc. - Dormant Projects 27
Melior Discovery, Inc. - Discontinued Pipeline Products 28
Discontinued Pipeline Product Profiles 28
MLR-1023 28
MLR-1045 28
MLR-1130 28
MLR-1362 28
Melior Discovery, Inc. - Locations And Subsidiaries 29
Head Office 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables
Melior Discovery, Inc., Key Information 5
Melior Discovery, Inc., Key Facts 5
Melior Discovery, Inc. - Pipeline by Indication, 2014 7
Melior Discovery, Inc. - Pipeline by Stage of Development, 2014 8
Melior Discovery, Inc. - Monotherapy Products in Pipeline, 2014 9
Melior Discovery, Inc. - Phase II, 2014 10
Melior Discovery, Inc. - IND/CTA Filed, 2014 11
Melior Discovery, Inc. - Preclinical, 2014 12
Melior Discovery, Inc. - Discovery, 2014 13
Melior Discovery, Inc. - Unknown, 2014 14
Melior Discovery, Inc. - Pipeline by Target, 2014 22
Melior Discovery, Inc. - Pipeline by Route of Administration, 2014 23
Melior Discovery, Inc. - Pipeline by Molecule Type, 2014 24
Melior Discovery, Inc. - Pipeline Products by Mechanism of Action, 2014 25
Melior Discovery, Inc. - Recent Pipeline Updates, 2014 26
Melior Discovery, Inc. - Dormant Developmental Projects,2014 27
Melior Discovery, Inc. - Discontinued Pipeline Products, 2014 28